Furthermore, disease progression assessed by the PC test was halted in zQ175DN+chol mice treated with 2 cycles starting at 29 weeks of age, and the improvement remained highly significant at 35 and 45 weeks of age ( Fig. 2 D).
← all excerpts
Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington's disease.
1
—
—